USS Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.96M | Sell |
114,592
-5,463
| -5% | -$427K | 0.05% | 225 |
|
|
2025
Q1 | $8.7M | Buy |
120,055
+1,884
| +2% | +$137K | 0.06% | 221 |
|
|
2024
Q4 | $8.75M | Sell |
118,171
-12,911
| -10% | -$956K | 0.06% | 246 |
|
|
2024
Q3 | $8.65M | Sell |
131,082
-7,833
| -6% | -$517K | 0.06% | 271 |
|
|
2024
Q2 | $12.8M | Buy |
138,915
+3,961
| +3% | +$366K | 0.1% | 163 |
|
|
2024
Q1 | $12.9M | Buy |
134,954
+16,360
| +14% | +$1.56M | 0.11% | 156 |
|
|
2023
Q4 | $9.05M | Sell |
118,594
-12,000
| -9% | -$915K | 0.08% | 205 |
|
|
2023
Q3 | $9.05M | Buy |
130,594
+2,061
| +2% | +$143K | 0.1% | 197 |
|
|
2023
Q2 | $12.1M | Buy |
+128,533
| New | +$12.1M | 0.14% | 148 |
|
|
2023
Q1 | – | Sell |
-115,997
| Closed | -$8.65M | – | 583 |
|
|
2022
Q4 | $8.65M | Buy |
115,997
+1,542
| +1% | +$115K | 0.12% | 186 |
|
|
2022
Q3 | $9.47M | Sell |
114,455
-38,984
| -25% | -$3.23M | 0.14% | 153 |
|
|
2022
Q2 | $14.6M | Sell |
153,439
-7,433
| -5% | -$707K | 0.15% | 148 |
|
|
2022
Q1 | $18.9M | Buy |
160,872
+10,947
| +7% | +$1.29M | 0.16% | 137 |
|
|
2021
Q4 | $19.4M | Hold |
149,925
| – | – | 0.15% | 139 |
|
|
2021
Q3 | $17M | Buy |
149,925
+98,907
| +194% | +$11.2M | 0.14% | 147 |
|
|
2021
Q2 | $5.29M | Buy |
+51,018
| New | +$5.29M | 0.04% | 251 |
|
|
2021
Q1 | – | Sell |
-51,018
| Closed | -$4.66M | – | 617 |
|
|
2020
Q4 | $4.66M | Hold |
51,018
| – | – | 0.04% | 238 |
|
|
2020
Q3 | $4.07M | Buy |
51,018
+1,958
| +4% | +$156K | 0.04% | 245 |
|
|
2020
Q2 | $3.39M | Buy |
+49,060
| New | +$3.39M | 0.04% | 260 |
|